Drug Type Monoclonal antibody |
Synonyms |
Target- |
Mechanism Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Kairos Pharma Ltd.Startup |
Active Organization Kairos Pharma Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Cancer | Preclinical | US | Kairos Pharma Ltd.Startup | 31 Jan 2024 |
Neoplasms | Discovery | US | Kairos Pharma Ltd.Startup | 30 Jan 2022 |